-
Symbol
-
CGEM on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.0001 per share
-
Latest Disclosed Ownership
-
8.55M shares
-
Security Ownership
-
14.5%
Shares, Excluding Options vs Price
Value, Excluding Options
Lynx1 Capital Management LP ownership in Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share (CGEM)
2025-10-10 - Lynx1 Capital Management LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 8.55M shares of Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share (CGEM).
This represents 14.5% percent ownership of the company.
In their previous filing dated 2025-08-14, Lynx1 Capital Management LP had reported owning 4.4M shares, indicating an increase of 94.3% percent.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.